← Browse by Condition
Medical Condition

recurrent glioma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04794972 Phase 1
Recruiting

A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors

Enrollment
60 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
View Trial →